Dr. Reddy's to release Q3 FY14 results on February 11, 2014

  Dr. Reddy's to release Q3 FY14 results on February 11, 2014

     Earnings call slated for February 11, 2014 6.30 PM IST / 8.00 AM EST

Business Wire

HYDERABAD, India -- January 10, 2014

Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the Third
Quarter ended December 31, 2013 on Tuesday, February 11, 2014 after the Board
Meeting. The results will be available on the Company’s website
www.drreddys.com

Summary of Events

Event                  Date and Time (IST)      Medium
Release of financial     February 11, 2014          Email, Media, Company
results                after the Board          website, Business Wire
                         Meeting
                         February 11, 2014 6.30     Hosted by the Company
Earnings Call          PM IST / 8:00 AM EST    
                                                    (Details below)
                         February 11, 2014 6.30     URL available on Company’s
Webcast of Earnings    PM IST / 8.00 AM EST     website,
Call                     through February 16,
                         2014                       www.drreddys.com
Transcripts of the     Will be available on     URL available on Company’s
Earnings call            the Company’s website      website, www.drreddys.com

Earnings Call

Following the release, the management of the Company will host an earnings
call to discuss the Company’s financial performance.

Conference Dial-In Numbers
Primary Number:           +91 22 3065 0136
Secondary Number:         +91 22 6629 0356
The numbers listed above are universally accessible from all networks and all
countries.
                          6000 1221
                          Available in - Ahmedabad, Bangalore, Bhubaneswar,
                          Chandigarh, Chennai, Coimbatore, Delhi, Goa, Guntur,
                          Gurgaon, Hyderabad, Indore, Jamshedpur, Kanpur,
                          Kochi/Cochin, Kolhapur, Kolkata, Nagpur, Noida,
                          Patna, Pune, Raipur, Rajkot, Surat, Trivandrum,
                          Vadodara, Vijayawada

Local Access Number:      Accessible from all major carriers except BSNL/MTNL.

                          3940 3977

                          Available in Ahmedabad, Bangalore, Chandigarh,
                          Chennai, Kochi/Cochin, Gurgaon (NCR), Hyderabad,
                          Kolkata, Lucknow, Pune

                          Accessible from all carriers.
                          USA: 1 866 746 2133
International Toll Free   UK: 0 808 101 1573
Number:                   Singapore: 800 101 2045
                          Hong Kong: 800 964 448

No password/pin number is necessary to dial in to any of the other calls. As
participation in the call is limited, early registration is encouraged. The
operator will provide instructions on asking questions before and during the
call.

Audio Webcast

The audio webcast of the earnings call will be available to all interested
parties at www.drreddys.com. Please visit the web site at least fifteen
minutes ahead of the scheduled start time to register and to download and
install any necessary audio software. Participants in the webcast can listen
to the proceedings, but will not be able to ask questions. The replay will be
available 2 hours after the earnings call, through February 16, 2014. For play
back dial in phone No: 022 3065 1212 and ID: 375#.

Transcript

The transcript of the earnings call will also be available on the Company's
website.

About Dr. Reddy’s

Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) is an integrated global
pharmaceutical company, committed to providing affordable and innovative
medicines for healthier lives. Through its three businesses - Pharmaceutical
Services and Active Ingredients, Global Generics and Proprietary Products –
Dr. Reddy’s offers a portfolio of products and services including APIs, custom
pharmaceutical services, generics, biosimilars and differentiated
formulations. Major therapeutic focus is on gastro-intestinal, cardiovascular,
diabetology, oncology, pain management and anti-infective. Major markets
include India, USA, Russia-CIS and Europe apart from other select geographies
within Emerging Markets.

For more information, log on to: www.drreddys.com

Contact:

Investor Relations:
Dr. Reddy's Laboratories
Kedar Upadhye at kedaru@drreddys.com / +91 40 66834297
Saunak Savla at saunaks@drreddys.com / +91 40 49002135
Milan Kalawadia (USA) at mkalawadia@drreddys.com / +1 9082034931
 
Press spacebar to pause and continue. Press esc to stop.